Monthly Archives: May 2024

US FDA finds Merck’s widely used asthma drug impacts the brain

US FDA finds Merck’s widely used asthma drug impacts the brain

U.S. government investigators have found that an asthma drug previously sold by Merck & Co may be linked to serious mental health problems in some patients, according to a scientific report reviewed by Reuters. Researchers found that the drug, sold under the brand names Singulair and montelukast, binds to several …

Read More »